Miroslav Gašpárek

Miroslav Gašpárek is a Slovak entrepreneur and co-founder of Sensible Biotechnologies, a startup focused on developing genetically modified cells for the natural production of mRNA. His innovative approach aims to transform the pharmaceutical industry by enabling the creation of new medications. Recently, Gašpárek's work attracted significant attention, culminating in a $13 million investment from Sartorius Stedim Biotech, highlighting the potential impact of his technology on healthcare in Europe and beyond.